SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001564590-20-046132
Filing Date
2020-10-08
Accepted
2020-10-08 17:22:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 srne-424b3.htm 424B3 336921
2 GRAPHIC gkloi4fxtfbv000002.jpg GRAPHIC 3210
3 GRAPHIC gkloi4fxtfbv000001.jpg GRAPHIC 3210
  Complete submission text file 0001564590-20-046132.txt   347141
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-249178 | Film No.: 201231557
SIC: 2836 Biological Products, (No Diagnostic Substances)